Form 13-F position report

DYNAVAX TECHNOLOGIES CORP COM

Reported by Invesco Ltd

DVAX CUSIP 268158201 Manager CIK 0000914208

Reported 1,288,156 shares, up 721,133 (127.2%) from the prior quarter.

Reported value 163.8%; share count 127.2% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q2 2022
Shares 1,288,156 Quarter-end amount reported
Reported value $16,218,000 Fair value at quarter end
Consecutive quarters held 7 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 11724000
2021-12-31 7854000
2022-03-31 6147000
2022-06-30 16218000
2022-09-30 14312000
2022-12-31 13921833
2023-03-31 13251818
2023-06-30 15876057
2023-09-30 15318957
2023-12-31 13628809
2024-03-31 13332883
2024-06-30 12337323
2024-09-30 19032123
2024-12-31 21065201
2025-03-31 28632974
2025-06-30 9780920
2025-09-30 10058635
2025-12-31 16693913
2026-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

19 quarters
Quarterly reported position history for DYNAVAX TECHNOLOGIES CORP COM held by Invesco Ltd.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2026 Reduced 0 -1,085,430 (-100.0%) 0 $0 2026-05-12
Q4 2025 Added 1,085,430 +72,476 (7.2%) < 0.01% $16,693,913 2026-02-19
Q3 2025 Added 1,012,954 +26,974 (2.7%) < 0.01% $10,058,635 2025-11-13
Q2 2025 Reduced 985,980 -1,221,651 (-55.3%) < 0.01% $9,780,920 2025-08-13
Q1 2025 Added 2,207,631 +558,046 (33.8%) < 0.01% $28,632,974 2025-05-12
Q4 2024 Reduced 1,649,585 -58,864 (-3.4%) < 0.01% $21,065,201 2025-02-13
Q3 2024 Added 1,708,449 +609,845 (55.5%) < 0.01% $19,032,123 2024-11-12
Q2 2024 Added 1,098,604 +24,238 (2.3%) < 0.01% $12,337,323 2024-08-13
Q1 2024 Added 1,074,366 +99,487 (10.2%) < 0.01% $13,332,883 2024-05-14
Q4 2023 Reduced 974,879 -62,288 (-6.0%) < 0.01% $13,628,809 2024-02-13
Q3 2023 Reduced 1,037,167 -191,630 (-15.6%) < 0.01% $15,318,957 2023-11-13
Q2 2023 Reduced 1,228,797 -122,051 (-9.0%) < 0.01% $15,876,057 2023-08-11
Q1 2023 Added 1,350,848 +42,405 (3.2%) < 0.01% $13,251,818 2023-05-12
Q4 2022 Reduced 1,308,443 -62,495 (-4.6%) < 0.01% $13,921,833 2023-02-13
Q3 2022 Added 1,370,938 +82,782 (6.4%) < 0.01% $14,312,000 2022-11-14
Q2 2022 Added 1,288,156 +721,133 (127.2%) < 0.01% $16,218,000 2022-08-15
Q1 2022 Added 567,023 +8,810 (1.6%) < 0.01% $6,147,000 2022-05-16
Q4 2021 Reduced 558,213 -52,073 (-8.5%) < 0.01% $7,854,000 2022-02-14
Q3 2021 Added 610,286 +571,050 (1455.4%) < 0.01% $11,724,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

239 managers reported DYNAVAX TECHNOLOGIES CORP COM for Q2 2022.

Managers reporting DYNAVAX TECHNOLOGIES CORP COM in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 18,561,894 +10,767,432 < 0.01% $233,694,000 31 qtrs
FEDERATED HERMES INC Reduced 16,022,731 -515,107 0.55% $201,726,000 31 qtrs
STATE STREET CORPORATION Added 8,629,427 +130,695 < 0.01% $108,644,000 32 qtrs
Bain Capital Life Sciences Investors LLC Unchanged 8,415,000 0 12.42% $105,945,000 12 qtrs
VANGUARD GROUP INC Added 8,023,967 +2,180,769 < 0.01% $101,023,000 31 qtrs
Chicago Capital LLC Reduced 5,842,906 -12,806 4.06% $73,562,000 18 qtrs
Fisher Asset Management LLC Added 4,288,848 +777,683 0.04% $53,997,000 5 qtrs
PFM Health Sciences LP Unchanged 3,805,370 0 1.83% $47,910,000 9 qtrs
BLAIR WILLIAM & CO IL Reduced 2,525,526 -25,922 0.14% $31,796,000 31 qtrs
EDMOND DE ROTHSCHILD HOLDING S A Reduced 2,320,000 -125,000 0.71% $29,209,000 17 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 15, 2022
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
0
Shared
1,231,540
None
56,616

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.